CD33 and acute myeloid leukemia: Additional CD33 SNPs genotyping studies focused on five further SNPs potentially affecting GO efficacy in adult AML patients—rs1803254(G > C; 30 UTR), rs35112940(G > A; Arg304Gly), rs2455069(A > G; Arg69Gly), rs61736475(Ser305Pro), and rs201074739 (CCGG deletion) [83].